Product Name | MF | CAS | Details |
---|
1-(4-Chlorophenyl)-3,3-difluorocyclobutane-1-carboxylic acid | C11H9ClF2O2 | 1190643-85-6 | Details |
(3R)-3-{[(tert-Butoxy)carbonyl]amino}pyrrolidine-3-carboxylic acid | C10H18N2O4 | 2173637-53-9 | Details |
Rabbit anti Dog IgG (H + L) (Texas Red) | Details |
1-[5-(Dimethylamino)pyridin-2-yl]ethan-1-ol | C9H14N2O | 1557879-32-9 | Details |
4,6-Dichloro-5-nitropyrimidine | C4HCl2N3O2 | 4316-93-2 | Details |
PSMB5 antibody | Details |
Annexin A8-Like 2 Blocking Peptide | Details |
2-tert-Butyl-1H-imidazole-4-carbaldehyde | C8H12N2O | 68282-60-0 | Details |
2,5-Anhydro-1-O-trityl-D-mannitol | C25H26O5 | 68774-48-1 | Details |
KISS1R antibody | Details |
6-Bromo-2-oxo-1,2-dihydroquinoline-4-carboxylic acid | C10H6BrNO3 | 5463-29-6 | Details |
2-Hydroxyethyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate | C13H18N2O4 | 1536264-82-0 | Details |
AKR1C3 protein (His tag) | Details |
RCM 1 | C20H12N2OS4 | 339163-65-4 | Details |
F111B antibody | Details |
Affinity Purified anti-Mouse IgG3 Antibody | Details |
Nevirapine | C15H14N4O | 129618-40-2 | Details |
4-tert-Butylbenzoic acid | C11H14O2 | 98-73-7 | Details |
Methyl 2-[(5-bromo-2-nitrophenyl)amino]-2-methylpropanoate | C11H13BrN2O4 | 1803589-02-7 | Details |
4-Chloro-2,3-dihydro-1-benzofuran-3-amine hydrochloride | C8H9Cl2NO | 1384265-47-7 | Details |
N5-Methyllamotrigine | C10H9Cl2N5 | 1373243-86-7 | Details |
Kaempferol-3-O-rhamnoside | C21H20O10 | 482-39-3 | Details |
Ketoprofen - Bio-X ? | C16H14O3 | 22071-15-4 | Details |
1-(2’-Deoxy-2’-fluoro-b-D-arabinofuranosyl)-N3-[3-(tert-butoxycarbonyl)amino]propyluracil | C17H26FN3O7 | 2072145-18-5 | Details |
Erythromycin, Antibiotic for Culture Media Use Only | C37H67NO13 | 114-07-8 | Details |
HK3 antibody | Details |
2,6-Difluoro-4-methylaniline | C7H7F2N | 1379028-84-8 | Details |
Propargyl-PEG4-CH2COOH | C13H22O7 | 1429934-37-1 | Details |
3-Deoxy-3-fluoro-D-xylofuranose - Aqueous solution | C5H9FO4 | 14537-01-0 | Details |
4-Ethyl-2,3-dihydro-1,3-thiazole-2-thione | C5H7NS2 | 33120-75-1 | Details |
1-(2,4-Dichlorophenyl)-1H-pyrazol-3-amine | C9H7Cl2N3 | 90273-59-9 | Details |
6-Bromo-4-chloro-1,3-dioxaindane | C7H4BrClO2 | 72736-55-1 | Details |
4-Chloro-2-nitrophenyl b-D-galactopyranoside | C12H14ClNO8 | Details |
2,3,4,6-Tetra-O-Acetyl-α-D-Glucopyranosyl Fluoride | C14H19FO9 | 3934-29-0 | Details |
3-(Difluoromethyl)azetidin-3-ol hydrochloride | C4H8ClF2NO | 1909316-00-2 | Details |
2-(Pyridin-3-yl)propanoic acid | C8H9NO2 | 90005-62-2 | Details |
Anhydrovinblastine N’B-oxide sulfate salt | C46H58N4O13S | 1796934-70-7 | Details |
1-(3-Methoxypyridin-4-yl)ethan-1-amine | C8H12N2O | 1196733-04-6 | Details |
Imidazol-1-ylacetonitrile | C5H5N3 | 98873-55-3 | Details |
Indatuximab ravtansine | 1238517-16-2 | Details |
2-bromo-5,6-dihydro-4h-benzothiazol-7-one | C7H6BrNOS | 1201633-72-8 | Details |
RBM22 Blocking Peptide | Details |
(Diacetyl)-a-MSH trifluoroacetate salt | C79H111N21O20S | 71952-90-4 | Details |
6-Chloro-1,3-dimethyluracil | C6H7ClN2O2 | 6972-27-6 | Details |
2-(1,3-Benzothiazol-2-yl)-3-[(2,5-dimethylphenyl)amino]-3-sulfanylprop-2-enenitrile | C18H15N3S2 | 379255-62-6 | Details |
N-(Carbamothioylamino)-2-phenylacetamide | C9H11N3OS | 29313-28-8 | Details |
Trioctyltin chloride | C24H51ClSn | 2587-76-0 | Details |
L-Cysteine hydrochloride anhydrous | C3H8ClNO2S | 52-89-1 | Details |
Methyl 5-bromo-2-iodobenzoate | C8H6BrIO2 | 181765-86-6 | Details |
Ascrinvacumab | 1463459-96-2 | Details |
Interiotherin C | C30H36O10 | 460090-65-7 | Details |
1-(Pyrrolidin-3-ylmethyl)piperidine | C10H20N2 | 933742-03-1 | Details |
F8 antibody | Details |
(Z)-Flunarizine | C26H26F2N2 | 693765-11-6 | Details |
ACOX1 antibody | Details |
N-(2,2,2-Trifluoroethyl)morpholine-4-carbothioamide | C7H11F3N2OS | 639520-25-5 | Details |
Cytochrome P450 2E1 antibody | Details |
1,7-Dioxaspiro[4.4]nonan-4-amine | C7H13NO2 | 2137477-43-9 | Details |
N-(2-Methoxyphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine | C11H14N2OS | 27779-18-6 | Details |
OR6T1 antibody | Details |
N-Methylethane-1-sulfonamide | C3H9NO2S | 6601-37-2 | Details |
3-[(5-Aminopyridin-2-yl)oxy]benzamide | C12H11N3O2 | 1016778-72-5 | Details |
5-[(Benzyloxy)carbonyl]-1H-pyrrole-2-carboxylic acid | C13H11NO4 | 848352-99-8 | Details |
Methyl 2,2-dimethyl-3-[(piperidin-4-yl)amino]propanoate | 1870131-28-4 | Details |
Chondroitin disaccharide di-0S sodium salt | C14H20NNaO11 | 136132-69-9 | Details |
1-[5-(Oxolan-2-yl)-1,2,4-oxadiazol-3-yl]cycloheptan-1-amine hydrochloride | C13H21N3O2.HCl | 1423032-20-5 | Details |
1-Myristoyl-d27-2-myristoyl-sn-glycero-3-phosphocholine | C36H45D27NO8P | 185906-02-9 | Details |
H-SYSMEHFR^-OH | Details |
1-(5-methyl-3-((2-phenylethyl)amino)-2,4-thiazolyl)ethan-1-one | C14H16N2OS | 196797-05-4 | Details |
3,4-Dihydrospiro[1,4-benzoxazine-2,4'-oxane] | C12H15NO2 | 2126935-75-7 | Details |
TFII-I antibody (Tyr248) | Details |
N-(2,2,2-Trifluoroethyl)-3-(trifluoromethyl)aniline | C9H7F6N | 201466-87-7 | Details |
6-Ethoxypyridine-2-carbaldehyde | C8H9NO2 | 85259-47-8 | Details |
Ethyl({[1-(prop-2-yn-1-yl)-1H-pyrazol-3-yl]methyl})amine hydrochloride | C9H14ClN3 | 1803586-39-1 | Details |
4-[(Diethylamino)methyl]-1,3-thiazol-2-amine | C8H15N3S | 859632-64-7 | Details |
RAD16-I trifluoroacetate salt | C66H113N29O25 | 289042-25-7 | Details |
ITPA protein (His tag) | Details |
3-Methyl-5-[3-(trifluoromethyl)pyrrolidin-3-yl]-1,2,4-oxadiazole hydrochloride | C8H11ClF3N3O | 2060039-97-4 | Details |
RWDD2A Blocking Peptide | Details |
C18-Reversed phase silica gel - for column chromatography, fully end-capped | Details |
5-[(4-Cyclopropylpiperazin-1-yl)methyl]pyridin-2-amine | C13H20N4 | 1457441-68-7 | Details |
5-Amino-2-(difluoromethoxy)benzonitrile hydrochloride | C8H7ClF2N2O | 1803606-66-7 | Details |
4-Acetylthiomorpholine-3-carbothioamide | C7H12N2OS2 | 1936720-96-5 | Details |
Cytidine-5'-triphosphoric acid disodium salt | C9H17N3NaO14P3 | 18423-42-2 | Details |
3-[[2-Nitro-4-(Trifluoromethyl)Phenyl]Amino]-1,2-Propanediol | C10H11F3N2O4 | 104333-00-8 | Details |
2-Methylcyclopentane-1-sulfonamide | C6H13NO2S | 1489918-40-2 | Details |
1-(5-Bromopyridin-3-yl)methanamine dihydrochloride | C6H7BrN2 | 1001414-82-9 | Details |
5-(2-Aminoethyl)-2-methoxybenzene-1-sulfonamide hydrochloride | C9H15ClN2O3S | 125960-58-9 | Details |
N-(3-(tert-butyl)-2-methyl-4-oxoindeno[3,2-c]pyrazol-6-yl)-2-methylpropanamide | C19H23N3O2 | 634154-97-5 | Details |
6-Chloroisoquinoline-1-carbaldehyde | C10H6ClNO | 1537415-87-4 | Details |
5-Bromo-3-(butan-2-yl)-1H-pyrrolo[2,3-b]pyridine | 2137707-46-9 | Details |
7-Chloro-N-(4-methylcyclohexyl)quinolin-4-amine | C16H19ClN2 | 1040320-71-5 | Details |
Tert-butyl 2-(cyclopropylmethylamino)ethylcarbamate | C11H22N2O2 | 532407-11-7 | Details |
Bovine Ig fraction | Details |
2-Iodo-4-methylthiopyrimidine | C5H5IN2S | 1000576-08-8 | Details |
H-GFPSVLR-OH | Details |
SP1 antibody | Details |
2-Hydrazinyl-6-(pyridin-3-yl)pyridine | C10H10N4 | 39883-46-0 | Details |
Ac-SIT-NH2 | Details |
1,2,3,4-Tetrahydroisoquinolin-7-ol | C9H11NO | 30798-64-2 | Details |
Product Total: Product Page: | ||||
105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 |